"Glossy drawings and new press releases cannot disguise the reality: this project poses serious risks and still faces a ...

Biohaven › On a very good Friday for the stock market, Biohaven's (NYSE: BHVN) performance was exceptional. The clinical-stage biotech's share price inflated by over 6% that trading session thanks to ...

Levi & Korsinsky, LLP notifies investors in Biohaven Ltd. ("Biohaven Ltd." or the "Company") (NYSE: BHVN) of a class action securities lawsuit.

Biohaven Ltd. (NYSE:BHVN) stock is trading higher on Friday following an update with respect to its New Drug Application for ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

Biohaven (NYSE:BHVN) stock gains as the FDA cancels an advisory meeting scheduled to review its marketing application for ...

The latest announcement is out from Biohaven Ltd. ( (BHVN) ).

Investing.com -- Biohaven Ltd. (NYSE: BHVN) stock rose 3% Friday morning after the company announced that the U.S. Food and Drug Administration (FDA) no longer plans to hold an advisory committee ...

About Robbins LLP : A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LL have been dedicated to helping shareholders recover losses, improve corporate governance ...

In a report released on August 15, William Pickering from Bernstein maintained a Buy rating on Biohaven Ltd., with a price target of $34.00. The company’s shares closed last Friday at $15.71. Take ...